Travere Therapeutics Inc TVTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:23 PM EDT
6.00quote price arrow up+0.47 (+8.59%)
Volume
834,629
52 week range
5.12 - 22.75
Loading...
  • Open5.54
  • Day High6.11
  • Day Low5.54
  • Prev Close5.53
  • 52 Week High22.75
  • 52 Week High Date05/01/23
  • 52 Week Low5.12
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap457.034M
  • Shares Out76.11M
  • 10 Day Average Volume1.45M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change-33.04

KEY STATS

  • Open5.54
  • Day High6.11
  • Day Low5.54
  • Prev Close5.53
  • 52 Week High22.75
  • 52 Week High Date05/01/23
  • 52 Week Low5.12
  • 52 Week Low Date04/25/24
  • Market Cap457.034M
  • Shares Out76.11M
  • 10 Day Average Volume1.45M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change-33.04

RATIOS/PROFITABILITY

  • EPS (TTM)-4.72
  • P/E (TTM)-1.27
  • Fwd P/E (NTM)-1.92
  • EBITDA (TTM)-332.899M
  • ROE (TTM)-308.90%
  • Revenue (TTM)145.238M
  • Gross Margin (TTM)92.12%
  • Net Margin (TTM)-259.11%
  • Debt To Equity (MRQ)187.87%

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Travere Therapeutics Inc

 

Profile

MORE
Travere Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. Sparsentan is also in late-stage development for focal segmental glomerulosclerosis (FSGS). The Company’s Pegtibatinase is a novel...
Gary Lyons
Independent Chairman of the Board
Eric Dube Ph.D.
President, Chief Executive Officer, Director
Christopher Cline
Chief Financial Officer
Address
3611 Valley Centre Dr, Suite 300
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
HROW
Harrow Inc
10.46+0.28+2.70%
CSTL
Castle Biosciences Inc
22.20+1.11+5.26%
ESPR
Esperion Therapeutics Inc
2.11+0.14+7.11%
AMRN
Amarin Corporation PLC
0.8341-0.0868-9.4256%
VNDA
Vanda Pharmaceuticals Inc
4.79+0.03+0.63%